You just read:

Rising Drug-Resistance Rates Continue to Erode the Utility of Frontline Antibiotics, Driving Uptake of New Antibiotic Brands in the Hospital-Treated Gram-Negative Infections Market

News provided by

Decision Resources Group

Mar 15, 2017, 13:30 ET